Report: Pharma and R&D prioritize AI, digital transformation
The life sciences industry confronts challenges like legacy systems and data silos, hindering AI and data science utilization. This white paper reveals how pharma and biopharma are prioritizing digital transformation to speed up drug discovery and development.
Topics include:
- Tackling data silos to boost cross-functional collaboration with a unified platform
- Robust data governance for quality, security, and AI compliance
- Reproducibility's role in regulatory compliance and AI trust
Adopting a platform approach helps extract more value from data and AI. Learn how Domino Data Lab's platform fosters digital innovation in pharma and R&D in the full eBook.